Skip to main content

Want a detailed portfolio tracker?

Enveric Biosciences (ENVB) P/E (2015 - 2026)

Enveric Biosciences (ENVB) P/E from Jun 24, 2015 to Jul 21, 2026. The TTM Enveric Biosciences (ENVB) P/E is -0.08. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Enveric Biosciences (ENVB)

YearP/EChange
2026-0.08-42.25%
2025-0.14-81.53%
2024-0.75-87.69%
2023-6.08+335.17%
2022-1.40-95.23%
2021-29.28-18.44%
2020-35.90+737.64%
2019-4.29-63.79%
2018-11.83-89.89%
2017-117.09-65.88%
2016-343.12-108.40%
20154.09KN/A

Comparison Enveric Biosciences (ENVB) P/E with competitors

Enveric Biosciences (ENVB) P/E is -0.08.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-102.13%
NBYStablecoin Development Corp0.00-105.39%
ENLVEnlivex Ltd0.07-193.68%
FGENFibroGen Inc0.24-400.62%
CHRSCoherus Biosciences Inc0.85-1162.67%
FBIOFortress Biotech Inc0.95-1288.54%
ORMPOramed Pharmaceuticals Inc1.50-1982.38%
AGENAgenus Inc3.01-3869.15%
INVAInnoviva Inc3.15-4049.99%
VXRTVaxart Inc3.55-4545.58%
CRMDCorMedix Inc3.63-4644.14%
CVACCureVac N.V.4.45-5667.61%
GLPGGalapagos NV4.86-6185.11%
SRPTSarepta Therapeutics Inc4.88-6214.17%
ABEOAbeona Therapeutics Inc5.39-6847.14%
ABUSArbutus Biopharma Corp5.60-7107.77%
ZVRAZevra Therapeutics Inc5.89-7472.97%
SPROSpero Therapeutics Inc6.23-7900.30%
CGENCompugen Ltd6.31-8007.38%
RIGLRigel Pharmaceuticals6.87-8706.35%
SLXNSilexion Therapeutics Corp7.30-9237.38%
OMEROmeros Corporation9.26-11695.37%
AUPHAurinia Pharmaceuticals Inc9.58-12103.90%
PLXProtalix BioTherapeutics Inc10.89-13739.56%
ACADAcadia Pharmaceuticals Inc11.73-14788.46%
TBPHTheravance Biopharma Inc12.26-15456.75%
ADMAAdma Biologics Inc12.42-15652.12%
HRMYHarmony Biosciences Holdings Inc13.82-17408.01%
SABSSAB Biotherapeutics Inc14.14-17803.77%
NAGENiagen Bioscience Inc14.82-18657.80%
INCYIncyte Corp15.82-19915.72%
REGNRegeneron Pharmaceuticals Inc15.86-19958.43%
PBYIPuma Biotechnology Inc17.32-21785.70%
CPRXCatalyst Pharmaceuticals Inc17.44-21940.50%
EXELExelixis Inc17.54-22064.12%
TGTXTG Therapeutics Inc18.97-23852.57%
MDXGMimedx Group Inc20.55-25839.40%
XOMAXOMA Royalty Corp22.87-28748.38%
ARGXArgen X SE24.30-30530.95%
CTMXCytomX Therapeutics Inc24.82-31186.09%
XOMAOXOMA Royalty Corp25.34-31841.98%
HALOHalozyme Therapeutics Inc25.62-32191.28%
XOMAPXOMA Royalty Corp25.67-32249.39%
VRTXVertex Pharmaceuticals Inc27.99-35160.75%
RPRXRoyalty Pharma plc - Class A28.69-36028.43%
SLNOSoleno Therapeutics Inc29.02-36438.97%
ASNDAscendis Pharma A/S30.09-37779.30%
LGNDLigand Pharmaceuticals Inc - Class B37.91-47581.21%
APLSApellis Pharmaceuticals Inc39.02-48970.39%
BMRNBiomarin Pharmaceutical Inc42.21-52966.35%
KRYSKrystal Biotech Inc45.34-56888.41%
ONCBeiGene Ltd69.54-87192.87%
PHARPharming Group N.V.75.03-94062.49%
TECHBio-Techne Corp101.96-127793.31%
VCELVericel Corp109.92-137766.17%
ALNYAlnylam Pharmaceuticals Inc117.96-147840.22%
GMABGenmab140.29-175801.03%
TLXTelix Pharmaceuticals Ltd162.15-203181.22%
CORTCorcept Therapeutics Inc212.86-266684.09%